A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes Mellitus

Clinical trial NCT07775404 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07775404
Sponsor: AstraZeneca
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight

Start date: 2026-08-28
Primary completion: 2028-04-20
Enrollment: 351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.